Baillie Gifford
Canvas Category Consultancy : Company : Venture Capital
To find you great growth opportunities, we seek the innovations and individuals that will drive change. Then we take a long-term approach, investing with conviction on your behalf. We are research-driven, patient and prepared to stand apart from the crowd. And because we’re an independent partnership without outside shareholders, you are our priority.
Assembly Line
Tekever raises $74M for dual-use drone platform deployed to Ukraine
Dual-use drone startup Tekever has raised €70 million ($74 million) to develop its product and expand into new markets, specifically the U.S. The news is part of a trend of smaller tech-driven startups moving into markets normally dominated by large “defense primes.”
Tekever’s funding round was led by Scottish investment company Baillie Gifford & Co. (which has previously backed SpaceX) and the NATO Innovation Fund, the €1 billion defense and dual-use VC fund announced in 2023. The fund is connected to NATO and focused on backing startups that build tech for categories like defense, security, and resilience.
SHINE Technologies Raises $70 Million Financing Round to Accelerate the Commercialization of Near-Term Applications of Fusion Technology
SHINE Technologies, LLC, a next-generation fusion technology company, today announced it has raised $70 million in additional funding. The round was led by existing investors including Baillie Gifford and Fidelity Management & Research Company, and also includes participation from new institutional investors. This round will complete the commercialization and scale-up of the company’s near-term applications of fusion technology, which are used in the industrial, defense, and healthcare markets.
SHINE is deploying a four-phased approach that commercializes fusion today while scaling its technology into the future. This approach provides important near-term economic and social benefits, while building a profitable foundation for the company to sustainably grow toward its longer term objectives in energy.
Joby Aviation to get investment from Tesla shareholder Baillie Gifford
British investment management firm Baillie Gifford will invest $180 million in electric aircraft maker Joby Aviation (JOBY.N), they said on Wednesday. This comes days after Joby clinched a $55 million contract extension to deliver up to nine air taxis to the U.S. Air Force, marking the company’s first revenue-generating operations.
Unlike other electric vertical takeoff and landing (eVTOL) manufacturers, which plan to sell aircraft to customers such as airlines and logistics companies, Joby’s business model is similar to a rideshare app.
Convoy Raises $260 Million to Accelerate Digital Freight Transformation
Convoy, the nation’s leading digital freight network, raised $260 million in new funding, comprised of a $160 million Series E preferred equity round led by Baillie Gifford and funds and accounts advised by T. Rowe Price Associates, Inc., as well as a $100 million venture-debt investment from Hercules Capital, Inc. (NYSE: HTGC). The company also secured a new $150 million line of credit from J.P. Morgan. This new funding will enable Convoy to accelerate the development of its efficiency-focused technologies in response to surging customer demand within the nation’s $800 billion trucking industry. With the most recent equity investment, Convoy is valued at $3.8 billion.
Zymergen Takes Aim at $3 Trillion Chemical & Materials Industry With $300 Million in New Funding
Science and material innovation company Zymergen today announced $300M in new investment to accelerate its delivery of revolutionary, high performance materials. The investment includes initial Series D funding led by Baillie Gifford, joined by Baron Capital Group and one of the world’s largest sovereign wealth funds, as well as additional growth financing from Perceptive Advisors. A number of current investors are also returning, and Zymergen expects to raise additional capital in Q4 as part of a Series D round.
This infusion of capital powers Zymergen’s charge into the $3 trillion chemical and materials industries, speeding the manufacture of their groundbreaking Hyaline film, as well as the commercialization of additional breakthrough products across electronics, agriculture, consumer care and healthcare. The investment announced today helps to bring the revolutionary Hyaline product to market more quickly, and accelerates Zymergen’s development of all-natural pesticides and other bio-derived crop protection products, as well as a bio-based insect repellent. These product innovations are supported by a powerful platform and technology infrastructure, protected by a strong and growing data set.